Facebook (FB) — The social networking giant is planning to launch in coming months a professional version of its social network site, a company executive told Reuters. — Shares of Kite Pharma, Inc. (KITE) are lower by more than 3% to $67.64 in pre-market trading on Thursday following the company’s pricing of its underwritten public […]
View the full post at: Morning Buzz: Facebook (FB), Kite Pharma (KITE), XOMA Corp. (XOMA), Digital Ally (DGLY), SunEdison (SUNE)
